180 related articles for article (PubMed ID: 12242338)
1. External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator.
Asada S; Choi Y; Yamada M; Wang SC; Hung MC; Qin J; Uesugi M
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12747-52. PubMed ID: 12242338
[TBL] [Abstract][Full Text] [Related]
2. A gene-expression inhibitor that targets an alpha-helix-mediated protein interaction.
Asada S; Choi Y; Uesugi M
J Am Chem Soc; 2003 Apr; 125(17):4992-3. PubMed ID: 12708845
[TBL] [Abstract][Full Text] [Related]
3. Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.
Goel A; Janknecht R
J Biol Chem; 2004 Apr; 279(15):14909-16. PubMed ID: 14747462
[TBL] [Abstract][Full Text] [Related]
4. A wrench-shaped synthetic molecule that modulates a transcription factor-coactivator interaction.
Shimogawa H; Kwon Y; Mao Q; Kawazoe Y; Choi Y; Asada S; Kigoshi H; Uesugi M
J Am Chem Soc; 2004 Mar; 126(11):3461-71. PubMed ID: 15025473
[TBL] [Abstract][Full Text] [Related]
5. A mammalian mediator subunit that shares properties with Saccharomyces cerevisiae mediator subunit Cse2.
Tomomori-Sato C; Sato S; Parmely TJ; Banks CA; Sorokina I; Florens L; Zybailov B; Washburn MP; Brower CS; Conaway RC; Conaway JW
J Biol Chem; 2004 Feb; 279(7):5846-51. PubMed ID: 14638676
[TBL] [Abstract][Full Text] [Related]
6. Ras induces mediator complex exchange on C/EBP beta.
Mo X; Kowenz-Leutz E; Xu H; Leutz A
Mol Cell; 2004 Jan; 13(2):241-50. PubMed ID: 14759369
[TBL] [Abstract][Full Text] [Related]
7. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of vaccination with plasmid DNA encoding for HER2/neu or HER2/neu-eGFP fusion protein against prostate cancer in rats.
Bhattachary R; Bukkapatnam R; Prawoko I; Soto J; Morgan M; Salup RR
Int Immunopharmacol; 2002 May; 2(6):783-96. PubMed ID: 12095169
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM).
Iwasaki T; Chin WW; Ko L
J Biol Chem; 2001 Sep; 276(36):33375-83. PubMed ID: 11443112
[TBL] [Abstract][Full Text] [Related]
10. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Yang Z; Barnes CJ; Kumar R
Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
[TBL] [Abstract][Full Text] [Related]
11. SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.
Kato H; Tjernberg A; Zhang W; Krutchinsky AN; An W; Takeuchi T; Ohtsuki Y; Sugano S; de Bruijn DR; Chait BT; Roeder RG
J Biol Chem; 2002 Feb; 277(7):5498-505. PubMed ID: 11734557
[TBL] [Abstract][Full Text] [Related]
12. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.
Ko L; Cardona GR; Chin WW
Proc Natl Acad Sci U S A; 2000 May; 97(11):6212-7. PubMed ID: 10823961
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of a soluble ESX-binding core domain of SUR2.
Jeon KH; Jun KY; Kim EY; Kwon Y
Prep Biochem Biotechnol; 2013; 43(4):364-75. PubMed ID: 23464919
[TBL] [Abstract][Full Text] [Related]
16. Dithiiranylmethyloxy azaxanthone shows potent anti-tumor activity via suppression of HER2 expression and HER2-mediated signals in HER2-overexpressing breast cancer cells.
Nam JM; Jeon KH; Kwon H; Lee E; Jun KY; Jin YB; Lee YS; Na Y; Kwon Y
Eur J Pharm Sci; 2013 Oct; 50(2):181-90. PubMed ID: 23835029
[TBL] [Abstract][Full Text] [Related]
17. MRG15 activates the B-myb promoter through formation of a nuclear complex with the retinoblastoma protein and the novel protein PAM14.
Leung JK; Berube N; Venable S; Ahmed S; Timchenko N; Pereira-Smith OM
J Biol Chem; 2001 Oct; 276(42):39171-8. PubMed ID: 11500496
[TBL] [Abstract][Full Text] [Related]
18. Isoform-specific interaction of HP1 with human TAFII130.
Vassallo MF; Tanese N
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5919-24. PubMed ID: 11959914
[TBL] [Abstract][Full Text] [Related]
19. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells.
Ryo A; Liou YC; Wulf G; Nakamura M; Lee SW; Lu KP
Mol Cell Biol; 2002 Aug; 22(15):5281-95. PubMed ID: 12101225
[TBL] [Abstract][Full Text] [Related]
20. Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides.
Chiang SY; Burli RW; Benz CC; Gawron L; Scott GK; Dervan PB; Beerman TA
J Biol Chem; 2000 Aug; 275(32):24246-54. PubMed ID: 10818092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
